[Experience with using atropine in comatose and non-comatose doses in psychiatric clinical practice].
Treatment with atropine in comatose doses was given to 11 patients suffering from schizophrenia with obsessive disturbances. A favourable effect was noted when there were no hypochondriacal symptoms in the disease clinical picture. Twenty-two patients with neurotic states received atropine in non-comatose doses. Positive results were noted in patients with obsessions in the disease clinical picture, as well as in patients with reactive depressions. In patients with hypochondriacal disturbances, this form of the therapy appeared to be of no effect.
D000275:Adjustment Disorders / Q000628:therapy; D000293:Adolescent; D000328:Adult; D001285:Atropine / Q000008:administration & dosage*; D003128:Coma / Q000139:chemically induced*; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000628:therapy*; D009770:Obsessive Behavior / Q000628:therapy; D012559:Schizophrenia / Q000628:therapy*; D013577:Syndrome
D001285:Atropine
Opyt primeneniia atropina v komatoznykh i nekomatoznykh dozakh v psikhiatricheskoĭ praktike.